Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RV3-BB rotavirus vaccine in newborn infants
ACTRN12611001212943Phase 2Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of RV3-BB rotavirus vaccine in rotaviral diarrhea, sponsored by Murdoch Children's Research Institute. Started Jan 2012; status: completed.
02
Drugs
RV3-BB rotavirus vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on ACTRN12611001212943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001212943.